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Aims: To assess the potential value of chromosome in situ hybridisation (CISH), Ki-67, and telomerase
immunocytochemistry in liquid based cervical cytology to help detect carcinoma cells and precursors.
Method: Sixty ThinPrep processed cervical cytology samples were studied: 23 cases within the normal
limit, 13 low grade squamous intraepithelial lesions (LSILs), 10 high grade squamous intraepithelial lesions
(HSILs), six squamous cell carcinomas, three endocervical adenocarcinomas, two cervical adenosquamous
cell carcinomas, and three endometrial adenocarcinomas. CISH was performed with DNA probes specific
for the pericentromeric regions of chromosome 11 and 16. Hybridisation signals were visualised with the
streptavidin–biotin peroxidase technique. The monoclonal MIB1 and polyclonal TRT-H231 antibodies were
used to detect Ki-67 and telomerase immunoreactivity, respectively.
Results: Non-specific background staining was almost absent in CISH slides. Normal squamous and
glandular cells showed a diploid chromosomal pattern. A relative gain in chromosomes 11 and 16
(aneusomy) was seen in HSIL and the carcinomas (p,0.0001). In MIB1 stained smears, normal cells and
koilocytes showed inconspicuous immunoreactivity, whereas strongly immunoreactive nuclei were found in
cancer cells and HSIL (p,0.0001). Not only carcinoma and HSIL cells, but also some normal cells, showed
cytoplasmic staining for telomerase.
Conclusions: These preliminary results indicate that ThinPrep processed cervical smears are suitable for
CISH and immunocytochemical studies. The neoplastic squamous and glandular cells were easily identified
based on nuclear aneusomy and strong Ki-67 immuoreactivity in the context of abnormal nuclear
morphology. This is the first study to apply CISH in cervical cytology using an immunoenzymatic approach.
C
ervical cancer is one of the most common forms of
cancer in women worldwide. Cytological examination
of cervical smears is the most widely applied screening
method for cervical cancer and its precursors. However, the
success of the Papanicolaou smear test is limited with respect
to sensitivity and specificity. False negative rates for cervical
premalignant lesions and cervical cancer lie between 15% and
50% and false positive rates of approximately 30% have been
reported.1 Such suboptimal performance may be related to
the subjectivity of cytological diagnosis. ThinPrep processing,
an automated cytopreparatory method, has been reported to
produce good quality cervical cytology preparations.
Moreover, it allows the use of auxiliary laboratory techni-
ques, which may help to distinguish neoplastic from benign
diseases, and thus may further improve the efficiency of
cancer detection in cervical cytology.
A wide array of immunohistochemical and molecular
markers have been tested to evaluate their specificity in
staining dysplastic cells in cervical smears.2–8 Immuno-
histochemical detection of the MIB1 (Ki-67) antigen is one
of the most frequently used methods for studying cell
proliferation in cancer.9 We have shown in earlier studies
that Ki-67 expression in cervical carcinoma has prognostic
relevance.10 Immunocytochemical detection of Ki-67 was also
found to be useful in the evaluation of atrophic cervical
smears.11 12
‘‘ThinPrep processing, an automated cytopreparatory
method, has been reported to produce good quality
cervical cytology preparations’’
Another possible parameter is the assessment of telomer-
ase activity in cervical samples. We have shown previously,
by the polymerase chain reaction based telomeric repeat
amplification protocol (TRAP) assay, that telomerase activity
is present in all stages of cervical cancer, whereas such
activity is weak in the normal cervix, suggesting that it is an
early event in cancer.13 Telomerase activity in cancer lesions
was found to be quantitatively distinct from that in
premalignant lesions, which may mean a much more
pronounced activation of telomerase in cancers than in
squamous intraepithelial lesions (SILs).14 It has been
suggested that the telomerase assay using cervical scrapings
might be a useful screening method for cervical lesions,
especially when combined with a Papanicolaou smear test.15
The application of fluorescence in situ hybridisation (FISH)
as an adjunct to conventional cytology in diagnosing
malignant diseases has been reported.16–21 These studies take
advantage of the fact that, although normal cells are usually
diploid, many of the common malignant tumours harbour
numerical chromosomal abnormalities that can be detected
by FISH. Most of these chromosome in situ hybridisation
(CISH) studies use fluorescence for visualisation. In our
opinion, visualisation of such signals using a non-fluores-
cence immunoenzymatic approach might be a more con-
venient means of evaluation in pathology laboratories.22 23
The objective of our study was to assess the potential value
of CISH, Ki-67, and telomerase immunohistochemistry in
liquid based cytology samples for the detection of carcinoma
cells and precursors. To the best of our knowledge, this is the
Abbreviations: CIN, cervical intraepithelial neoplasia; CISH,
chromosome in situ hybridisation; FISH, fluorescence in situ
hybridisation; LSIL, low grade squamous intraepithelial lesion; HSIL, high
grade squamous intraepithelial lesion; ISH, in situ hybridisation; SIL,
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first report documenting such an application in ThinPrep
residues of cervical cytology samples.
MATERIALS AND METHODS
Clinical samples and preparation of slides
All ThinPrep reagents were obtained from Cytyc,
Boxborough, Massachusetts, USA. Sixty ThinPrep processed
cervical cytology samples were collected from the department
of pathology, Queen Mary Hospital, the University of Hong
Kong. Sampling was performed using a cervexbrush (Rovers
Medical Devices BV, Oss, the Netherlands), which was then
rinsed in the ThinPrep transport solution (PreservCyt). A
ThinPrep thin layer cytological smear was prepared from the
cell suspension using the ThinPrep 2000 processor.24 If
necessary, the specimens were treated with CytoLyt solution
to lyse red blood cells and remove mucous. Table 1 lists the
cytological diagnoses, which were subsequently confirmed by
follow up or biopsy data. The sediment was resuspended in
PreservCyt solution, and additional thin layer slides were
prepared using the ThinPrep 2000 processor and fixed in 95%
alcohol. These unstained ThinPrep slides remained in alcohol
until use for immunocytochemistry and CISH. The cytological
diagnosis was revealed only after the performance and
evaluation of the immunocytochemistry and CISH was
completed.
Chromosome in situ hybridisation
CISH was performed as described previously.22 23 25 DNA
probes specific for the pericentromeric regions of chromo-
some 11 (D11Z1) and chromosome 16 (D16Z3) (American
Type Culture Collection, Rockville, Maryland, USA) were
labelled with biotin by the nick translation method
(Boehringer, Mannheim, Germany). These probes were
chosen because, based on our experience, they produced
good CISH signals with little non-specific background that
would affect the interpretation.
ThinPrep cytology specimens were prepared using 2%
aminopropyltriethoxysilane coated slides from the ThinPrep
cellular residues of the above samples. The slides were stored
in 95% alcohol at room temperature until used for the CISH
studies. The slides were incubated first with sodium
thiocyanate (Sigma, St Louis, Missouri, USA) and then
proteinase K (250–500 mg/ml) and 0.1% Triton X-100 at 50 C˚.
The labelled probes were added to the hybridisation mix (60%
formamide, 10% dextran sulfate, and 26 saline sodium
citrate) and applied to the tissue sections at probe concentra-
tions of 1 ng/ml of hybridisation mixture. Denaturation was
performed at 90 C˚, followed by overnight hybridisation at
37 C˚. Immunocytochemistry was performed using avidin,
biotinylated mouse anti-avidin, rabbit antimouse peroxidase,
and 3,39-diaminobenzidine (Dakopatts Ltd, Ely,
Cambridgeshire, UK); hydrogen peroxidase was used to
visualise the peroxidase activity.
Scoring criteria of CISH
The criteria published by Florentine et al were followed.20 The
morphology of the nuclei was taken into consideration.
Around 10 to 100 cells were evaluated. Artefactual hyperdi-
ploidy—that is, nuclei that might be misinterpreted as
hyperdiploid as a result of artificial cellular clumping or
multinucleation—was ruled out. A sample was considered
malignant if at least four nuclei were hyperdiploid for one or
more chromosomes. The sample was considered inconclusive
if fewer numbers of these nuclei were seen or if artefactual
hyperdiploidy could not be ruled out. A sample was
considered benign (negative) if all of the nuclei analysed
gave diploid signals.
Table 1 Diagnosis of liquid based cytology samples used in our study
Cytological diagnosis Number of cases Histological diagnosis in follow up biopsy
Within normal limit 23
LSIL 13 CIN I and or condyloma (n = 9)
CIN II (n = 1)
Cervicitis (n = 1)
HSIL 10 CIN III (n = 3)
Squamous cell carcinoma (n = 2)
Squamous cell carcinoma 6 Squamous cell carcinoma (n = 6)
Endocervical adenocarcinoma 3 Endocervical adenocarcinoma (n = 3)
Cervical adenosquamous cell carcinoma 2 Adenosquamous cell carcinoma (n = 2)
Endometrial adenocarcinoma 3 Endometrial adenocarcinoma (n = 3)
CIN, cervical intraepithelial neoplasia; HSIL, high grade intraepithelial lesion; LSIL, low grade intraepithelial lesion.
Figure 1 Normal squamous and endocervical cells showing two copies
of the in situ hybridisation signals for chromosome 11.
Figure 2 Low grade squamous intraepithelial lesion (koilocytes)
showing two copies of the in situ hybridisation signals for chromosome
11.
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Immunocytochemistry for Ki-67 and telomerase
From the ThinPrep residue, ThinPrep thin layer cytology was
first prepared using the ThinPrep 2000 processor and dried
overnight in an oven at 37 C˚. Immunocytochemical studies
were performed using a streptavidin–biotin peroxidase
(Dako, Glostrup, Denmark) technique after preheating in a
microwave oven.26 Endogenous peroxidase was blocked using
3% H2O2 in distilled water. The slides were immersed in
10mM (pH 6) sodium citrate buffer in a thermoresistant
plastic box and were processed in a microwave oven for five
minutes at 700 W. The slides were then cooled in phosphate
buffered saline before immunostaining. The monoclonal
antibody MIB1 (Zymed Laboratories, South San Francisco,
California, USA) and the polyclonal antibody TRT-H231
(Santa Cruz Biotechnology, Santa Cruz, California, USA),
neat and at a 1/50 dilution, respectively, were applied.
Appropriate negative and positive controls were included.
Diaminobenzidine hydrogen peroxide was used as chromo-
gen. A light haematoxylin counterstain was used.
Scoring for Ki-67 and telomerase immunoreactivity
The whole slide was screened. At least 10 epithelial groups
with the highest immunoreactivity were evaluated and
marked in each smear. Cells with abnormal cytological
features were included for assessment. The expression of
Ki-67 and telomerase in the marked cell groups in each smear
was recorded as negative, inconclusive, or positive based on
the percentage of positive nuclei (, 10%, 10–50%, and
. 50%, respectively).11
RESULTS
Chromosome in situ hybridisation
Non-specific background staining was almost absent. Table 2
summarises the results of the CISH signal analysis. Normal
squamous and glandular cells (fig 1) and koilocytes (fig 2)
showed a diploid chromosomal pattern. A relative gain in
chromosomes 11 and 16 (aneusomy) was seen in high grade
SIL (HSIL; fig 3) and in the carcinomas. Smears within the
normal limit and low grade SIL (LSIL) were significantly
more likely to display disomy for chromosome 11
(p , 0.0001) and chromosome 16 (p , 0.0001) than were
HSIL or cancer cases.
Ki-67 immunoreacitvity
Immunoreactivity for the Ki-67 antigen was exclusively
confined to the nuclei, with no cytoplasmic staining detected.
Table 3 summarises the results of the Ki-67 staining analysis.
Normal squamous cells, koilocytes, and endocervical cells
showed a lack of immunoreactivity (fig 4). Only occasional
endometrial cells (fig 5) and mildly dyskaryotic cells in LSIL
showed nuclear staining. Numerous strongly immunoreac-
tive nuclei were found in all types of carcinoma cells (figs 6
and 7) available on the smear. HSIL cells (fig 8) were also Ki-
67 immunopositive. There was a significant difference in Ki-
67 immunoreactivity between the group containing normal
or LSIL cases and the group containing HSIL or cancer cases
(p , 0.0001).
Telomerase immunoreactivity
Telomerase immunoreactivity was found in both the nuclei
and the cytoplasm. Background staining was present in some
Figure 3 High grade squamous intraepithelial lesion (cervical
intraepithelial neoplasia III) showing multiple copies of the in situ
hybridisation signals for chromosome 11.

















Cases with .4 nuclei
with >3 ISH signals
Negative 23 23 0 0 23 0 0
LSIL 13 13 0 0 13 0 0
HSIL 10 0 1 9 0 2 8
SCC 6 0 0 6 0 0 6
Cx AdenoCA 3 0 1 2 0 1 2
Cx AdenoSqCA 2 0 0 2 0 0 2
Em AdenoCA 3 0 0 3 0 1 2
p,0.0001 p,0.0001
CISH, chromosome in situ hybridisation; Cx AdenoCA, endocervical adenocarcinoma; Cx AdenoSqCA, cervical adenosquamous cell carcinoma; Em AdenoCA,
endometrial adenocarcinoma; HSIL, high grade intraepithelial lesion; ISH, in situ hybridisation; LSIL, low grade intraepithelial lesion; negative, cases within the
normal limit; SCC, squamous cell carcinoma.
Figure 4 Koilocyte and normal squamous cells showing a lack of
reactivity for MIB-1 (Ki-67).
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cases. Table 4 summarises the results of the telomerase
staining analysis. The carcinoma cells and cells in HSIL (fig 9)
showed positive staining. Some koilocytes were also immu-
noreactive (fig 10). A negative or weakly positive reaction
was occasionally seen in some squamous cells (fig 11),
metaplastic cells, normal endocervical cells, and endometrial
cells. However, the staining was slightly stronger in cancer
cells and HSIL cells. There was no significant difference in
telomerase immunoreactivity between the group containing
normal or LSIL cases and the group containing HSIL or
cancer cases (p = 0.112).
DISCUSSION
The use of Papanicolaou smears to screen for cervical
carcinoma is widely recognised as an effective measure.
However, erroneous and equivocal diagnoses still exist.1 27
Various approaches are being explored to improve the
sensitivity and specificity of the test. In particular, human
papillomavirus testing has permitted the sensitive identifica-
tion of women who will progress to HSIL or even carcinoma.27
In addition, molecular and biological markers have been
tested for the detection of malignant cells in cervical smears.4–6
Because it is known that complex numerical chromosomal
abnormalities evolve during anaplastic transformation,22 23
in situ hybridisation can be performed in cytology speci-
mens,16 20 21 including cervical cytology samples,19 to evaluate
the chromosome composition.
‘‘Our approach using immunoenzymatic visualisation of in
situ hybridisation signals makes evaluation much easier
and the signals are more permanent’’
The liquid based cytological preparation technique has
been developed to collect exfoliated cervical cells in liquid
buffer for transportation to the cytology laboratory for
preparation as thin layer slides. It has received Food and
Drug Administration approval for clinical use. ThinPrep
cytology has shown an equivalent or increased rate of
detection of SIL and carcinoma in comparison with conven-
tional Papanicolaou smears.24 Because the production of a
ThinPrep slide uses only a fraction of the cells collected in
PreservCyt buffer, the residual cells remaining in the vial are
available for ancillary studies. It is hoped that this could
facilitate reliable detection and minimise equivocal diagnoses
based on a single clinical collection, without the need for
repeated patient appointments. Combined cytopathological
diagnosis and ancillary tests from PreservCyt specimens is an
interesting option.
Figure 5 Normal endometrial cells showing a lack of reactivity for MIB-
1 (Ki-67).
Figure 6 Endometrial carcinoma (grade I) showing reactivity for MIB-1
(Ki-67).
Figure 7 Endometrial carcinoma (grade III) showing extensive
reactivity for MIB-1 (Ki-67).
Figure 8 High grade intraepithelial lesion (cervical intraepithelial
neoplasia III) showing reactivity for MIB-1 (Ki-67).
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Most of the earlier studies analysing CISH on cytology
preparations use fluorescence approaches.16–21 28 Although
hyperdiploid signals could be detected, quantitative assess-
ment of in situ hybridisation (ISH) signals may be difficult in
such specimens, and may not be a convenient measure in the
routine cytology laboratory. Our approach using immunoen-
zymatic visualisation of ISH signals makes evaluation much
easier and the signals are more permanent. We found that
the detection of cells with chromosomal aneusomy is a
reliable marker for malignancy, including HSIL and different
types of cancer.
The number of abnormal cells in each slide varied in
different cases. In some cases, only a small number of
dysplastic or malignant cells could be identified for assess-
ment of the ISH signals. The interpretation is more reliable
when more abnormal cells are available for assessment.
However, the observation of a distinctly raised copy number
of targeted chromosomes indicates the high sensitivity of the
CISH test, which can highlight even small numbers of
abnormal cells.
Several studies have shown that Ki-67 immunocytochem-
istry can be used to distinguish proliferating and non-
proliferating cells in both histological and cytological speci-
mens.29–32 These studies showed that the number and
distribution of Ki-67 positive cells correlated well with the
grade of cervical intraepithelial neoplasia (CIN). The Ki-67
labelling index is low in normal cases and gradually increases
with CIN.33–35 Ki-67 immunoreactivity has been found to be a
useful and reliable proliferation marker in smears from
postmenopausal women.11 34
In our study, Ki-67 immunoreactivity was mostly positive
in HSIL and carcinoma cells and negative in normal cells and
LSIL, so that this marker could be used to distinguish
between these two groups. The findings suggest that Ki-67
could be a convenient and reliable marker to assist in the
cytological diagnosis in ThinPrep samples.
Telomerase is an enzyme that replenishes short stretches of
repeat nucleotides lost from the telomeric ends of chromo-
somes with each round of replication. Studies in both tumour
cell lines and human tumour specimens have shown that, in
contrast to normal somatic cells, most malignant cells are
characterised by increased telomerase activity.36–39 Telomerase
activity has been reported in association with CIN II/III and
cervical cancer, with a difference being seen between
premalignant and invasive cervical cancerous lesions.13 38 40 41
The determination of telomerase activity has been sug-
gested as a test for early cancer detection. Assessment of
telomerase activity in cervical scrapings has been reported to
be potentially useful for screening of cervical cancer even in
cases with a negative Papanicolaou smear and for triage of
women with borderline smears,42–47 and has thus been
explored as a molecular marker for cervical cancer screening.
We intended to investigate the usefulness of telomerase
immunocytochemistry in ThinPrep cell residues because this
could be a convenient way of assessing telomerase activity.
However, unfortunately, this was hampered by significant
background staining. Moreover, telomerase staining was
Table 3 Cytological diagnosis and results of Ki-67 immunocytochemistry
Cytological diagnosis No of cases
Ki-67
Negative Inconclusive Positive
Negative 23 23 0 0
LSIL 13 13 0 0
HSIL 10 0 2 8
SCC 6 0 1 5
Cx AdenoCA 3 0 0 3
Cx AdenoSqCA 2 0 0 2
Em AdenoCA 3 0 1 2
p,0.0001
Cx AdenoCA, endocervical adenocarcinoma; Cx AdenoSqCA, cervical adenosquamous cell carcinoma; Em
AdenoCA, endometrial adenocarcinoma; HSIL, high grade intraepithelial lesion; LSIL, low grade intraepithelial
lesion; negative, cases within the normal limit; SCC, squamous cell carcinoma.
Figure 9 High grade intraepithelial lesion (cervical intraepithelial
neoplasia III) showing immunoreactivity for telomerase.
Figure 10 Low grade intraepithelial lesion (koilocytes) showing
immunoreactivity for telomerase.
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unhelpful in the distinction between normal or LSIL samples
and any of the lesions examined. There may be several
reasons for this. The specificity of the antibody may be a
problem. Alternatively, these results also agree with our
recent findings that the detection of telomerase activity in
cervical scrapings by TRAP had no significant association
with HSIL.46
‘‘We found that the detection of cells with chromosomal
aneusomy is a reliable marker for malignancy, including
high grade squamous cell intraepithelial lesions and
different types of cancer’’
Our preliminary results indicate that ThinPrep processed
cervical smears are suitable for CISH and immunocytochem-
ical studies. The abnormal squamous and glandular cells
could easily be identified based on nuclear aneusomy and
strong Ki-67 immunoreactivity in the context of abnormal
nuclear morphology. CISH, Ki-67, and telomerase immuno-
cytochemistry in liquid based cervical cytology can assist in
the detection of carcinoma cells and precursors. To the best of
our knowledge, this is the first study illustrating the
application of CISH in cervical cytology using an immuno-
enzymatic approach, which may be a more convenient
approach in the service pathology laboratory. However, our
study was limited by the number of cases included for each
category and more cases should be studied to confirm this
application.
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